Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alpha Teknova (TKNO)
NASDAQ:TKNO
Holding TKNO?
Track your performance easily
TKNO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $5.46
Previous Close$5.1
Volume350.32K
Average Volume (3M)632.92K
Market Cap
$271.85M
Enterprise Value$284.22M
Total Cash (Recent Filing)$18.60M
Total Debt (Recent Filing)$30.98M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 06, 2024EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding53,302,993
10 Day Avg. Volume144,090
30 Day Avg. Volume632,919
Standard Deviation0.43
R-Squared0.00266
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)3.45
Price to Sales (P/S)7.78
Price to Cash Flow (P/CF)-24.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.42
Enterprise Value/Gross Profit27.61
Enterprise Value/Ebitda-14.89
Forecast
1Y Price Target
$6.00Price Target Upside17.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Alpha Teknova News
PremiumCompany Announcements
Alpha Teknova Reports Strong Q3 Revenue Growth
Bulls Say, Bears Say
Bulls Say
Cost ManagementOperating expenses were lower than expected as a result of disciplined cash burn management, including reduced capital spend and headcount.
Financial PerformanceQ1 revenues of $9.3M exceeded analyst expectations due to improving order trends and increased Clinical Solution revenues.
Future GrowthTKNO expects revenue growth in Lab Essentials segment.
Bears Say
Financial PerformanceGross margins decreased year over year, primarily due to increased overhead costs associated with the GMP manufacturing facility.
Revenue ExpectationsDemand for TKNO's business is closely tied to biotech funding, which is currently constrained.
Stock ValuationThe stock of TKNO is currently trading at a premium compared to its small cap peers, which may limit its upside potential.
---
Ownership Overview
65.95% Insiders
2.19% Mutual Funds
4.33% Other Institutional Investors
27.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TKNO FAQ
What was Alpha Teknova’s price range in the past 12 months?
Alpha Teknova lowest stock price was $1.16 and its highest was $5.46 in the past 12 months.
What is Alpha Teknova’s market cap?
Currently, no data Available
When is Alpha Teknova’s upcoming earnings report date?
Alpha Teknova’s upcoming earnings report date is Nov 06, 2024 which is 4 days ago.
How were Alpha Teknova’s earnings last quarter?
Alpha Teknova released its earnings results on Aug 13, 2024. The company reported -$0.13 earnings per share for the quarter, beating the consensus estimate of -$0.162 by $0.032.
Is Alpha Teknova overvalued?
According to Wall Street analysts Alpha Teknova’s price is currently Undervalued.
Does Alpha Teknova pay dividends?
Alpha Teknova does not currently pay dividends.
What is Alpha Teknova’s EPS estimate?
Alpha Teknova’s EPS estimate is -$0.11.
How many shares outstanding does Alpha Teknova have?
Alpha Teknova has 53,302,994 shares outstanding.
What happened to Alpha Teknova’s price movement after its last earnings report?
Alpha Teknova reported an EPS of -$0.13 in its last earnings report, beating expectations of -$0.162. Following the earnings report the stock price went down -6.549%.
Which hedge fund is a major shareholder of Alpha Teknova?
Among the largest hedge funds holding Alpha Teknova’s share is Platinum Investment Management. It holds Alpha Teknova’s shares valued at 728K.
---
Alpha Teknova Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (17.65% Upside)
$6.00 (17.65% Upside)
Hedge Fund Trend
Decreased
By 196.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $15.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 8.2%
Last 30 Days ▼ 8.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
171.27%
12-Months-Change
Fundamentals
Return on Equity
-41.51%
Trailing 12-Months
Asset Growth
-12.97%
Trailing 12-Months
Company Description
Alpha Teknova
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.
---
TKNO Company Deck
---
TKNO Earnings Call
Q2 2024
0:00 / 0:00
---
TKNO Stock 12 Month Forecast
Average Price Target
$6.00
▲(17.65% Upside)
Technical Analysis
Best Analysts Covering TKNO
1 Year
1 Year Success Rate
6/6 ratings generated profit
1 Year Average Return
+138.28%
assigned a buy rating 3 months ago
Copying Steven Mah's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +138.28% per trade.
---